New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
10:02 EDTDDD, OPTT, PCTY, QTWO, SRE, SSYS, ULTI, V, XOOM, MA, LNKD, ACRX, AGII, AI, APAM, BCRX, CPRX, ECOM, KIN, ZBRAOn The Fly: Analyst Initiation Summary
3D Systems (DDD) initiated with a Neutral at Goldman... AcelRx (ACRX) initiated with a Buy at Roth Capital... Argo Group (AGII) initiated with a Market Perform at Keefe Bruyette... Arlington Asset Investment (AI) initiated with a Neutral at Credit Suisse... Artisan Partners (APAM) initiated with an Outperform at RBC Capital... BioCryst (BCRX) initiated with an Outperform at Brinson Patrick... Catalyst Pharmaceutical (CPRX) initiated with an Overweight at Piper Jaffray... ChannelAdvisor (ECOM) initiated with a Buy at Janney Capital... Kindred Biosciences (KIN) initiated with an Outperform at Leerink... LinkedIn (LNKD) initiated with an Overweight at Atlantic Equities... MasterCard (MA) initiated with a Sector Perform at Pacific Crest... Ocean Power (OPTT) initiated with a Buy at H.C. Wainwright... Pandora (P) initiated with a Buy at SunTrust... Paylocity (PCTY) initiated with a Buy at Deutsche Bank... Q2 Holdings (QTWO) initiated with a Buy at Canaccord... Sempra Energy (SRE) initiated with a Buy at UBS... Stratasys (SSYS) initiated with a Buy at Goldman... Ultimate Software (ULTI) initiated with a Buy at Deutsche Bank... Visa (V) initiated with an Outperform at Pacific Crest... Xoom (XOOM) initiated with a Buy at Buckingham... Zebra Technologies (ZBRA) initiated with a Buy at Sidoti.
News For DDD;ACRX;AGII;AI;APAM;BCRX;CPRX;ECOM;KIN;LNKD;MA;OPTT;PCTY;QTWO;SRE;SSYS;ULTI;V;XOOM;ZBRA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
October 10, 2014
10:54 EDTBCRXMapp looking to up production of experimental Ebola treatment, WSJ says
Mapp Biopharmaceutical is aiming to broaden the manufacturing of its experimental Ebola treatment, ZMapp, according to The Wall Street Journal, citing comments from the company. Mapp said that the treatment was given to a few infected individuals prior to supplies running out two months ago. Drug companies that are working on experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT), BioCryst (BCRX), Chimerix (CMRX) and NewLink Genetics (NLNK). Reference Link
10:04 EDTXOOMXoom could be a acquisition of target of PayPal, says Monness Crespi
Subscribe for More Information
October 9, 2014
16:07 EDTAPAMArtisan Partners reports AUM $106.2B as of September 30
Artisan Partners reported that its assets under management as of September 30 totaled $106.2B. Separate accounts accounted for $45.3B of total firm AUM, while Artisan Funds and Artisan Global Funds accounted for $60.9B.
14:55 EDTBCRXHospital says deputy showing no signs of Ebola, AP reports
Subscribe for More Information
14:24 EDTBCRXCDC head compares Ebola to AIDS, Washington Post says
Subscribe for More Information
14:13 EDTBCRXFirst Ebola vaccine trial in West Africa started, NBC News reports
Subscribe for More Information
12:06 EDTBCRXLakeland Industries continues surge amid Ebola fears
Subscribe for More Information
10:31 EDTKINKindred Biosciences management to meet with Guggenheim
Subscribe for More Information
10:27 EDTACRXAcelRx management to meet with Guggenheim
Subscribe for More Information
10:00 EDTULTIOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:35 EDTULTIUltimate Software initiated with a Buy at MKM Partners
Subscribe for More Information
October 8, 2014
11:22 EDTBCRXChimerix falls after Ebola patient taking experimental drug dies
Shares of Chimerix (CMRX) are moving lower after the Texas Health Presbyterian Hospital Dallas announced that Thomas Eric Duncan succumbed to Ebola. Duncan was being treated with Chimerix's experimental drug Brincidofovir. Shares of Chimerix dropped 9% following the news to $30.19. Other makers of experimental Ebola treatments include Tekmira (TKMR), Sarepta (SRPT) and BioCryst (BCRX).
10:22 EDTKINKindred Biosciences management to meet with Leerink
Subscribe for More Information
10:21 EDTKINKindred Biosciences management to meet with Craig-Hallum
Subscribe for More Information
07:31 EDTDDD, SSYSFDA to hold a public workshop
Subscribe for More Information
07:11 EDTBCRXEuropean Academy of Dermatology and Venereology to hold a conference
23rd EADV Congress is being held in Amsterdam, The Netherlands on October 8-12.
October 7, 2014
10:02 EDTPCTYOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:45 EDTBCRXBioCryst up 2.2% after OPuS-1 Phase 2 trial met primary efficacy endpoint
Subscribe for More Information
07:14 EDTBCRXBioCryst announces OPuS-1 Phase 2 trial met primary efficacy endpoint
Subscribe for More Information
06:02 EDTVVisa's CIO leaves company to join Charles Schwab, Re/code reports
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use